Evaluation of Clinical Outcomes in Children with Intrahepatic Cholestasis Postpartial External Biliary Diversion: A

Hadeer Mohamed Nasr El-Din1, Noha Adel Yassin2, Nehal M El Koofy2

  • 1Pediatric Surgery Department, Cairo University Specialized Pediatric Hospital, Cairo University, Giza, Egypt.

Insights

Partial external biliary diversion (PEBD) effectively reduces severe itching in children with progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome (AGS). This safe surgical option improves quality of life and growth while preserving liver function.

Area of Science:

  • Hepatology
  • Pediatric Surgery
  • Gastroenterology

Background:

  • Severe pruritus in progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome (AGS) is often refractory to medical management.
  • Surgical interruption of the enterohepatic circulation is a key strategy for symptom relief and delaying cirrhosis.

Purpose of the Study:

  • To evaluate the short-term efficacy of partial external biliary diversion (PEBD) in pediatric patients with PFIC and AGS.
  • Assess the impact of PEBD on pruritus, liver disease progression, growth, and quality of life.

Main Methods:

  • Prospective cohort study of children with PFIC and AGS undergoing PEBD.
  • Outcomes measured using pruritus scores, quality of life scales (PedsQL), growth parameters, bile acid levels, and liver function tests.
  • Follow-up duration ranged from 6 to 12 months.

Main Results:

  • Significant improvement in pruritus (5-D itching score, p<0.001) and quality of life (PedsQL, p<0.001).
  • Marked reduction in bile acid levels (p=0.013) and amelioration of growth failure.
  • No significant changes in bilirubin or other liver function tests; no intra-operative complications.

Conclusions:

  • PEBD is an effective and safe treatment for intractable pruritus in PFIC and AGS.
  • The procedure helps preserve synthetic liver functions.
  • PEBD offers a viable surgical option for improving patient outcomes.
Abstract